Viewing Study NCT02669251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-22 @ 11:38 AM
Study NCT ID: NCT02669251
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2016-01-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Graft vs Host Disease View
None Chronic Graft-Versus-Host Disease View
None Bronchiolitis Obliterans Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Optimal Biologic Dose View
None Safety View
None Chronic Graft-Versus-Host Disease (cGVHD) View
None Inflammatory Lung Disease View
None FEV1 View